Tu1311 Validation of a Homogenous Mobility Shift Assay (HMSA) for the Measurement of Ustekinumab (UTK) and Antibodies-to-Ustekinumab (ATU) in Inflammatory Bowel Disease (IBD) Patient Serum
Year: 2015
Type: conference-abstract
Source: Gastroenterology
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2060743627
